scholarly article | Q13442814 |
P50 | author | Mien-Chie Hung | Q1532952 |
Joe E. Ensor | Q40421901 | ||
Frank J Lowery | Q56871266 | ||
Sunil Acharya | Q86705772 | ||
P2093 | author name string | Lin Zhang | |
Aysegul A Sahin | |||
Jia Xu | |||
Jun Yao | |||
Ping Li | |||
Xiang H-F Zhang | |||
Dihua Yu | |||
Yi Xiao | |||
Qingling Zhang | |||
Hai Wang | |||
Ozgur Sahin | |||
Yohei Saito | |||
Jitao David Zhang | |||
Wen-Ling Kuo | |||
P2860 | cites work | 14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition | Q24313042 |
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach | Q24633776 | ||
Genes that mediate breast cancer metastasis to the brain | Q24644008 | ||
Latent bone metastasis in breast cancer tied to Src-dependent survival signals | Q24648828 | ||
TGF-β/SMAD/GLI2 signaling axis in cancer progression and metastasis | Q27008239 | ||
Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease | Q28202655 | ||
Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo | Q28237073 | ||
TGFβ signalling in context | Q28275410 | ||
TGFbeta in Cancer | Q28288866 | ||
Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response | Q28297156 | ||
Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice | Q28361871 | ||
Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors | Q28588676 | ||
Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis | Q28592128 | ||
A multigenic program mediating breast cancer metastasis to bone | Q29614308 | ||
Metastasis to bone: causes, consequences and therapeutic opportunities | Q29614310 | ||
Specificity and versatility in tgf-beta signaling through Smads | Q29616324 | ||
Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation | Q33202126 | ||
Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis | Q33292546 | ||
Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers. | Q33755493 | ||
Molecular mechanisms of bone metastasis and associated muscle weakness | Q33758508 | ||
A novel role for 14-3-3sigma in regulating epithelial cell polarity | Q33816790 | ||
S6K1 promotes invasiveness of breast cancer cells in a model of metastasis of triple-negative breast cancer | Q33961949 | ||
Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study | Q34480536 | ||
Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells | Q34580134 | ||
Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas | Q35581149 | ||
Targeting the TGFβ signalling pathway in disease | Q36462348 | ||
Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins. | Q36477042 | ||
Restriction of intestinal stem cell expansion and the regenerative response by YAP. | Q36508081 | ||
14-3-3σ Positively Regulates p53 and Suppresses Tumor Growth | Q36549508 | ||
ATM kinase enables the functional axis of YAP, PML and p53 to ameliorate loss of Werner protein-mediated oncogenic senescence. | Q37219985 | ||
Targeting the p53 pathway | Q37260683 | ||
Yes-associated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53. | Q37269206 | ||
Roles of TGFbeta in metastasis | Q37339711 | ||
YAP: at the crossroad between transformation and tumor suppression | Q37357685 | ||
Upregulation of neutrophil gelatinase-associated lipocalin by ErbB2 through nuclear factor-kappaB activation | Q37479941 | ||
Proteomic analysis identifies that 14-3-3zeta interacts with beta-catenin and facilitates its activation by Akt. | Q37593591 | ||
Gain or loss of TGFbeta signaling in mammary carcinoma cells can promote metastasis | Q37608885 | ||
A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis | Q37631216 | ||
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal | Q37909890 | ||
The Hippo pathway and human cancer. | Q38087215 | ||
PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. | Q38357857 | ||
Overexpression of 14-3-3ζ in cancer cells activates PI3K via binding the p85 regulatory subunit | Q38712325 | ||
Yes-associated protein (YAP) functions as a tumor suppressor in breast. | Q39962753 | ||
Gli2 is targeted for ubiquitination and degradation by beta-TrCP ubiquitin ligase. | Q40285122 | ||
A structural basis for 14-3-3sigma functional specificity. | Q40454476 | ||
Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads. | Q40649890 | ||
Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways | Q42520359 | ||
An alternative DNA damage pathway to apoptosis in hematological cancers | Q46698546 | ||
Programmed cell senescence during mammalian embryonic development. | Q50709155 | ||
Roles for negative cell regulator 14-3-3σ in control of MDM2 activities | Q58884817 | ||
14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling | Q80869587 | ||
MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer | Q85936182 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell biology | Q7141 |
breast cancer | Q128581 | ||
P304 | page(s) | 177-192 | |
P577 | publication date | 2015-02-01 | |
P1433 | published in | Cancer Cell | Q280018 |
P1476 | title | 14-3-3ζ turns TGF-β's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2 | |
P478 | volume | 27 |
Q92026075 | 14-3-3 Proteins Are on the Crossroads of Cancer, Aging, and Age-Related Neurodegenerative Disease |
Q57790420 | 14-3-3ζ binds to hepatitis B virus protein X and maintains its protein stability in hepatocellular carcinoma cells |
Q41547594 | 14-3-3ζ loss impedes oncogene-induced mammary tumorigenesis and metastasis by attenuating oncogenic signaling |
Q47134911 | 14-3-3ζ loss leads to neonatal lethality by microRNA-126 downregulation-mediated developmental defects in lung vasculature |
Q37696252 | 14-3-3ζ/TGFβR1 promotes tumor metastasis in lung squamous cell carcinoma |
Q38711211 | A microRNA signature of response to erlotinib is descriptive of TGFβ behaviour in NSCLC. |
Q91985663 | Activation of the Ca2+ sensing receptor and the PKC/WNK4 downstream signaling cascade induces incorporation of ZO-2 to tight junctions and its separation from 14-3-3 |
Q36203725 | Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer |
Q52691464 | Bone metastasis pattern in initial metastatic breast cancer: a population-based study. |
Q60048560 | Causal Inference Network of Genes Related with Bone Metastasis of Breast Cancer and Osteoblasts Using Causal Bayesian Networks |
Q55367849 | Checkpoint suppressor 1 suppresses transcriptional activity of ERα and breast cancer cell proliferation via deacetylase SIRT1. |
Q38810340 | Context-Specific Effects of TGF-β/SMAD3 in Cancer Are Modulated by the Epigenome. |
Q36270042 | Deep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targets |
Q39027205 | Dichotomous roles of TGF-β in human cancer |
Q36958371 | Downregulation of GLUT4 contributes to effective intervention of estrogen receptor-negative/HER2-overexpressing early stage breast disease progression by lapatinib |
Q64054816 | Evaluating cell lines as models for metastatic breast cancer through integrative analysis of genomic data |
Q47319130 | Expanding horizons: new roles for non-canonical RNA-binding proteins in cancer. |
Q48026313 | Expediting dynamics approach to understand the influence of 14-3-3ζ causing metastatic cancer through the interaction of YAP1 and β-TRCP. |
Q94552657 | Expression of yhwaz and gene regulation network in hepatocellular carcinoma |
Q31155755 | For robust big data analyses: a collection of 150 important pro-metastatic genes |
Q55339912 | Gamma synuclein is a novel Twist1 target that promotes TGF-β-induced cancer cell migration and invasion. |
Q94481933 | Glucocorticoid receptors are required effectors of TGFβ1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer |
Q64265772 | HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis |
Q38795536 | Identification of 14-3-3zeta associated protein networks in oral cancer |
Q42700861 | Identification of a novel YAP-14-3-3ζ negative feedback loop in gastric cancer |
Q36346393 | Mathematical model of TGF-βsignalling: feedback coupling is consistent with signal switching. |
Q49919334 | Mechanistic insight into contextual TGF-β signaling. |
Q57233384 | Molecular Cloning and Effects of -Silencing on Larval Survivability Against and in |
Q38776336 | Molecular insights into tumour metastasis: tracing the dominant events. |
Q38616107 | Moonlighting proteins in cancer. |
Q35744180 | PEAK1 Acts as a Molecular Switch to Regulate Context-Dependent TGFβ Responses in Breast Cancer |
Q59755807 | PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis |
Q91710991 | PSPC1 potentiates TGF-β-dependent metastatic dissemination |
Q91930594 | Phosphorylation of 14-3-3ζ links YAP transcriptional activation to hypoxic glycolysis for tumorigenesis |
Q91999274 | Pleiotropic tumor suppressor functions of WWOX antagonize metastasis |
Q104617805 | Pregnancy-specific glycoprotein 9 acts as both a transcriptional target and a regulator of the canonical TGF-β/Smad signaling to drive breast cancer progression |
Q33705623 | Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells |
Q51109576 | SND1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGFβ1 response and breast cancer metastasis. |
Q26744502 | Sirtuins and Cancer: Role in the Epithelial-Mesenchymal Transition |
Q93022835 | Sphingosine Kinase 1 Signaling Promotes Metastasis of Triple-Negative Breast Cancer |
Q33836444 | Suppression Of β-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma |
Q49234750 | Suppressor of fused (Sufu) promotes epithelial-mesenchymal transition (EMT) in cervical squamous cell carcinoma |
Q28079488 | Switching Roles of TGF-β in Cancer Development: Implications for Therapeutic Target and Biomarker Studies |
Q39155158 | TGF-β Family Signaling in Tumor Suppression and Cancer Progression. |
Q49488316 | TGF-β signaling in cancer metastasis. |
Q92723914 | TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis |
Q38786658 | Targeting metastasis |
Q61814439 | Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases |
Q55176168 | The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma. |
Q50901931 | The Attenuation of 14-3-3ζ is Involved in the Caffeic Acid-Blocked Lipopolysaccharide-Stimulated Inflammatory Response in RAW264.7 Macrophages. |
Q89144664 | The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein-protein interactions |
Q28468629 | The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer |
Q90012713 | The role of YWHAZ in cancer: A maze of opportunities and challenges |
Q36433122 | Tipping the balance between good and evil: aberrant 14-3-3ζ expression drives oncogenic TGF-β signaling in metastatic breast cancers |
Q64123052 | Towards control of cellular decision-making networks in the epithelial-to-mesenchymal transition |
Q37728585 | Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis |
Q37376527 | Upregulation of lactate dehydrogenase a by 14-3-3ζ leads to increased glycolysis critical for breast cancer initiation and progression |
Q38705131 | Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells |
Q90428400 | YWHAE/14-3-3ε expression impacts the protein load contributing to proteasome inhibitor sensitivity in multiple myeloma |
Q92837837 | YWHAZ amplification/overexpression defines aggressive bladder cancer and contributes to chemo-/radio-resistance by suppressing caspase-mediated apoptosis |
Q94076879 | 乳腺癌患者的粒系分化异常现象和TGF-β1的矛盾转换调节作用 |